Reality will soon come to medical practices specifically geared to individuals based on genetic makeup. A report issued by the HHS pinpoints work that lies ahead for the government, biotechnology and pharmaceutical companies. The possibility of predicting health, preventing and preempting disease, and personalizing treatment based on an individual's unique biology will have a profound effect on the healthcare system.
In a audio conference from BioWorld Today and Medical Device Daily, Dan Mendelson, of Avalere Health, will discuss trends in personalized medicine and their implications for commercialization strategies for emerging therapeutics and medical technologies. "Personalized Medicine: Transforming Healthcare and Creating Opportunity," just $349 per listening site, is scheduled for Nov. 27 at 1 p.m. to 2:30 p.m. EST. It includes presentation handouts and a half-hour Q&A session. A CD (MP3 format) also is available. For information, call 800-688-2421 or 404-262-5474, and mention conference code T08482.